Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 18 studies | 26% ± 8% | |
oligodendrocyte precursor cell | 11 studies | 36% ± 16% | |
smooth muscle cell | 10 studies | 22% ± 8% | |
endothelial cell | 3 studies | 18% ± 4% |
Insufficient scRNA-seq data for expression of CSPG4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 73% | 12155.97 | 1051 / 1445 | 81% | 44.47 | 149 / 183 |
skin | 55% | 2286.49 | 1002 / 1809 | 97% | 310.83 | 456 / 472 |
uterus | 96% | 9627.10 | 164 / 170 | 51% | 18.34 | 236 / 459 |
breast | 78% | 6354.07 | 356 / 459 | 64% | 14.95 | 720 / 1118 |
lung | 97% | 6974.08 | 562 / 578 | 44% | 14.18 | 511 / 1155 |
brain | 37% | 1146.93 | 972 / 2642 | 96% | 61.19 | 679 / 705 |
bladder | 86% | 10973.24 | 18 / 21 | 45% | 11.73 | 227 / 504 |
prostate | 80% | 5384.68 | 196 / 245 | 49% | 7.38 | 244 / 502 |
intestine | 82% | 12771.56 | 788 / 966 | 45% | 8.34 | 238 / 527 |
stomach | 54% | 5618.58 | 195 / 359 | 56% | 14.42 | 161 / 286 |
blood vessel | 100% | 34474.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 127.04 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.36 | 1 / 1 |
adipose | 99% | 9918.37 | 1186 / 1204 | 0% | 0 | 0 / 0 |
thymus | 41% | 1435.64 | 265 / 653 | 49% | 7.62 | 295 / 605 |
kidney | 22% | 857.08 | 20 / 89 | 62% | 37.68 | 560 / 901 |
muscle | 84% | 8270.59 | 674 / 803 | 0% | 0 | 0 / 0 |
heart | 75% | 3066.21 | 646 / 861 | 0% | 0 | 0 / 0 |
ovary | 46% | 2541.08 | 82 / 180 | 23% | 3.39 | 98 / 430 |
pancreas | 1% | 14.12 | 2 / 328 | 63% | 11.82 | 113 / 178 |
adrenal gland | 1% | 31.24 | 3 / 258 | 53% | 14.35 | 122 / 230 |
tonsil | 0% | 0 | 0 / 0 | 44% | 20.49 | 20 / 45 |
spleen | 42% | 1316.06 | 101 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 14% | 2.26 | 57 / 406 |
peripheral blood | 0% | 5.16 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0097178 | Biological process | ruffle assembly |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0048008 | Biological process | platelet-derived growth factor receptor signaling pathway |
GO_0048771 | Biological process | tissue remodeling |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0006929 | Biological process | substrate-dependent cell migration |
GO_0008347 | Biological process | glial cell migration |
GO_0001726 | Cellular component | ruffle |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005796 | Cellular component | Golgi lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005925 | Cellular component | focal adhesion |
GO_0009986 | Cellular component | cell surface |
GO_0031258 | Cellular component | lamellipodium membrane |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0015026 | Molecular function | coreceptor activity |
GO_0019901 | Molecular function | protein kinase binding |
Gene name | CSPG4 |
Protein name | CSPG4 protein Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan) Alternative protein CSPG4 |
Synonyms | MCSP |
Description | FUNCTION: Proteoglycan playing a role in cell proliferation and migration which stimulates endothelial cells motility during microvascular morphogenesis. May also inhibit neurite outgrowth and growth cone collapse during axon regeneration. Cell surface receptor for collagen alpha 2(VI) which may confer cells ability to migrate on that substrate. Binds through its extracellular N-terminus growth factors, extracellular matrix proteases modulating their activity. May regulate MPP16-dependent degradation and invasion of type I collagen participating in melanoma cells invasion properties. May modulate the plasminogen system by enhancing plasminogen activation and inhibiting angiostatin. Functions also as a signal transducing protein by binding through its cytoplasmic C-terminus scaffolding and signaling proteins. May promote retraction fiber formation and cell polarization through Rho GTPase activation. May stimulate alpha-4, beta-1 integrin-mediated adhesion and spreading by recruiting and activating a signaling cascade through CDC42, ACK1 and BCAR1. May activate FAK and ERK1/ERK2 signaling cascades. . |
Accessions | ENST00000308508.5 Q6UVK1 L8E9X8 A2VCL1 |